Literature DB >> 19453664

Increase in metabolic syndrome as defined by ATPIII from 1992-1993 to 2002-2003 in a Mediterranean population.

Genevieve G Buckland1, Jordi Salas-Salvadó, Lluís Serra-Majem, Conxa Castell, Juanjo Cabré, Lluis Salleras-Sanmartí.   

Abstract

This paper presents the results of a study that aimed to describe the prevalence and evolution of metabolic syndrome (MetS) in the Mediterranean population of Catalonia, Spain, between 1992-1993 and 2002-2003 by applying the National Cholesterol Education Program's Adult Treatment Panel III (ATPIII) and International Diabetes Federation (IDF) definitions. Data from two cross-sectional population-based surveys were used (ENCAT 1992-1993 [n = 820] and 2002-2003 [n = 1,384]). Applying IDF definitions, MetS tended to increase (P = 0.08), from 25% in 1992-1993 to 28.5% in 2002-2003. Applying ATPIII definitions, MetS prevalence was lower, and it increased significantly (P < 0.001) from 18.4% in 1992-1993 to 24.8% in 2002-2003. MetS prevalence is high and has increased significantly in the last decade in Catalonia.

Entities:  

Mesh:

Year:  2009        PMID: 19453664     DOI: 10.1111/j.1753-4887.2009.00173.x

Source DB:  PubMed          Journal:  Nutr Rev        ISSN: 0029-6643            Impact factor:   7.110


  1 in total

1.  Validation of metabolic syndrome using medical records in the SUN cohort.

Authors:  Maria Teresa Barrio-Lopez; Maira Bes-Rastrollo; Juan Jose Beunza; Alejandro Fernandez-Montero; Martin Garcia-Lopez; Miguel Angel Martinez-Gonzalez
Journal:  BMC Public Health       Date:  2011-11-15       Impact factor: 3.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.